Phase I abuse liability trial of intranasally administered benzhydrocodone/paracetamol (KP 201), compared with hydrocodone/paracetamol.

Trial Profile

Phase I abuse liability trial of intranasally administered benzhydrocodone/paracetamol (KP 201), compared with hydrocodone/paracetamol.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2016

At a glance

  • Drugs Benzhydrocodone/paracetamol (Primary) ; Hydrocodone/paracetamol
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors KemPharm
  • Most Recent Events

    • 09 Sep 2016 According to a KemPharm media release, the results will be presented at the annual meeting PAINWeek 2016.
    • 08 Sep 2016 Results published in a KemPharm media release.
    • 06 Jun 2016 Data will be presented at the 2016 International Conference on Opioids (ICOO), according to a KemPharm media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top